In this presentation, the complexities of genetic testing in ADPKD, recommendations on when genetic testing is appropriate and indicated, and the various types of molecular genetic tests available will be… Read More
This presentation focuses on the impact of kidney disease and autosomal dominant polycystic kidney disease (ADPKD) in Black and Hispanic/Latino communities and the effects of social determinants of health on… Read More
In this presentation rapid disease progression of autosomal dominant polycystic kidney disease (ADPKD) will be defined. The risk factors that assist in determining if a patient is at risk of… Read More
This presentation focuses on the pediatric patient populations of both autosomal dominant polycystic kidney disease (ADPKD) and autosomal recessive polycystic kidney disease (ARPKD). Read More
As we approach the new year, it’s an ideal time to look back over the past year and celebrate the many developments and progress made in overcoming barriers, improving the… Read More
This on-demand webinar discusses hyperuricemia, its effects and relations to chronic kidney disease and ADPKD. Read More
NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the Kidney Health Community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.